High-Dose Vitamin Supplement Linked to Higher Cognitive Scores in Early Dementia Study

Industry Pulse News Desk · 2026-08-27

A study by Emory University researchers found adults with early cognitive decline and sleep issues scored higher on cognitive tests after taking high-dose vitamin supplements.

ATLANTA — Adults experiencing early signs of dementia alongside sleep disturbances demonstrated improved cognitive performance after taking high doses of a common dietary vitamin, according to a study conducted by researchers at Emory University.

The clinical investigation focused on participants presenting with mild cognitive impairment paired with reported sleep disruption. Subjects who took a daily dosage of at least 5,000 international units of the supplement showed a measurable increase in standard neurological assessments compared to baseline measurements.

On average, individuals in the high-dosage group scored four points higher on a comprehensive brain performance test. Researchers noted that the combination of early cognitive decline and sleep loss often accelerates neurological deterioration, making targeted interventions a critical area of study.

Neurological examinations evaluated memory retention, executive functioning, and processing speed among the subjects. While the preliminary results indicate a positive association between the specific vitamin regimen and test scores, investigators emphasized that further clinical trials are necessary to determine long-term outcomes and optimal dosing parameters.

The findings contribute to ongoing clinical research examining how metabolic and nutritional factors influence neurodegenerative progression in aging populations. Detailed statistical breakdowns and methodology from the trial are expected to inform future therapeutic protocols.